Color Doppler US and tri-phasic CT in differentiating benign from malignant portal vein thrombosis (PVT)

Objective: To evaluate the efficacy of color Doppler US and tri-phasic CT in discriminating benign from malignant PVT. Patients and methods: This study included 30 patients presented ultrasonically with PVT and referred for color Doppler US and Tri-phasic CT examination for discriminating the benign...

Full description

Bibliographic Details
Main Authors: Atef H. Teama, Aly A. Elbarbary, Khaled E. Elhawary, Wafaa A. Abusekina
Format: Article
Language:English
Published: SpringerOpen 2015-12-01
Series:The Egyptian Journal of Radiology and Nuclear Medicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0378603X15002016
_version_ 1818408714667819008
author Atef H. Teama
Aly A. Elbarbary
Khaled E. Elhawary
Wafaa A. Abusekina
author_facet Atef H. Teama
Aly A. Elbarbary
Khaled E. Elhawary
Wafaa A. Abusekina
author_sort Atef H. Teama
collection DOAJ
description Objective: To evaluate the efficacy of color Doppler US and tri-phasic CT in discriminating benign from malignant PVT. Patients and methods: This study included 30 patients presented ultrasonically with PVT and referred for color Doppler US and Tri-phasic CT examination for discriminating the benign from malignant PVT. The color Doppler US and tri-phasic CT results were compared and correlated with available histopathological results in the patients who had FNAC. Results: Those 30 patients were classified according to US, Tri-phasic CT, lab., findings into two groups: G.(A) included 16 patients with malignant PVT and G.(B) included 14 patients with benign PVT. Intrathrombus pulsatile flow was depicted in 12 patients with malignant PVT (12/16) (75%), while non-depicted in 14 patients with benign PVT with 100% specificity. On tri-phasic CT, neovascularity and an early arterial enhancement of PVT were depicted in 14 cases with malignant PVT with 87.5% sensitivity and non-depicted in 14 benign cases with PVT with 100% specificity. Conclusion: Distinguishing benign from malignant PVT in patients with HCC is required to determine the management plan. The color Doppler study of PVT should be an essential step in evaluation of patients with HCC. The combination of Color Doppler US and tri-phasic CT is common and essential for more accurate evaluation and differentiation of benign from malignant PVT.
first_indexed 2024-12-14T09:48:07Z
format Article
id doaj.art-616b32f4642a472e9be405217dad029b
institution Directory Open Access Journal
issn 0378-603X
language English
last_indexed 2024-12-14T09:48:07Z
publishDate 2015-12-01
publisher SpringerOpen
record_format Article
series The Egyptian Journal of Radiology and Nuclear Medicine
spelling doaj.art-616b32f4642a472e9be405217dad029b2022-12-21T23:07:35ZengSpringerOpenThe Egyptian Journal of Radiology and Nuclear Medicine0378-603X2015-12-0146484785710.1016/j.ejrnm.2015.09.002Color Doppler US and tri-phasic CT in differentiating benign from malignant portal vein thrombosis (PVT)Atef H. Teama0Aly A. Elbarbary1Khaled E. Elhawary2Wafaa A. Abusekina3Radiodiagnosis & Medical Imaging Department, Faculty of Medicine, Tanta University, EgyptRadiodiagnosis & Medical Imaging Department, Faculty of Medicine, Tanta University, EgyptRadiodiagnosis Department, National Liver Institute, Menoufia University, EgyptRadiodiagnosis Department, Shebin-Elkom Teaching Hospital, EgyptObjective: To evaluate the efficacy of color Doppler US and tri-phasic CT in discriminating benign from malignant PVT. Patients and methods: This study included 30 patients presented ultrasonically with PVT and referred for color Doppler US and Tri-phasic CT examination for discriminating the benign from malignant PVT. The color Doppler US and tri-phasic CT results were compared and correlated with available histopathological results in the patients who had FNAC. Results: Those 30 patients were classified according to US, Tri-phasic CT, lab., findings into two groups: G.(A) included 16 patients with malignant PVT and G.(B) included 14 patients with benign PVT. Intrathrombus pulsatile flow was depicted in 12 patients with malignant PVT (12/16) (75%), while non-depicted in 14 patients with benign PVT with 100% specificity. On tri-phasic CT, neovascularity and an early arterial enhancement of PVT were depicted in 14 cases with malignant PVT with 87.5% sensitivity and non-depicted in 14 benign cases with PVT with 100% specificity. Conclusion: Distinguishing benign from malignant PVT in patients with HCC is required to determine the management plan. The color Doppler study of PVT should be an essential step in evaluation of patients with HCC. The combination of Color Doppler US and tri-phasic CT is common and essential for more accurate evaluation and differentiation of benign from malignant PVT.http://www.sciencedirect.com/science/article/pii/S0378603X15002016Portal vein thrombosisColor Doppler USTri-phasic CT
spellingShingle Atef H. Teama
Aly A. Elbarbary
Khaled E. Elhawary
Wafaa A. Abusekina
Color Doppler US and tri-phasic CT in differentiating benign from malignant portal vein thrombosis (PVT)
The Egyptian Journal of Radiology and Nuclear Medicine
Portal vein thrombosis
Color Doppler US
Tri-phasic CT
title Color Doppler US and tri-phasic CT in differentiating benign from malignant portal vein thrombosis (PVT)
title_full Color Doppler US and tri-phasic CT in differentiating benign from malignant portal vein thrombosis (PVT)
title_fullStr Color Doppler US and tri-phasic CT in differentiating benign from malignant portal vein thrombosis (PVT)
title_full_unstemmed Color Doppler US and tri-phasic CT in differentiating benign from malignant portal vein thrombosis (PVT)
title_short Color Doppler US and tri-phasic CT in differentiating benign from malignant portal vein thrombosis (PVT)
title_sort color doppler us and tri phasic ct in differentiating benign from malignant portal vein thrombosis pvt
topic Portal vein thrombosis
Color Doppler US
Tri-phasic CT
url http://www.sciencedirect.com/science/article/pii/S0378603X15002016
work_keys_str_mv AT atefhteama colordopplerusandtriphasicctindifferentiatingbenignfrommalignantportalveinthrombosispvt
AT alyaelbarbary colordopplerusandtriphasicctindifferentiatingbenignfrommalignantportalveinthrombosispvt
AT khaledeelhawary colordopplerusandtriphasicctindifferentiatingbenignfrommalignantportalveinthrombosispvt
AT wafaaaabusekina colordopplerusandtriphasicctindifferentiatingbenignfrommalignantportalveinthrombosispvt